Phoenix Biotech Acquisition Corp. (PBAX)

NASDAQ: PBAX · IEX Real-Time Price · USD
+0.01 (0.10%)
At close: Sep 29, 2022 4:00 PM
-0.01 (-0.10%)
After-hours: Sep 30, 2022 4:57 PM EDT
Market Cap 232.11M
Revenue (ttm) n/a
Net Income (ttm) -315,547
Shares Out 22.98M
EPS (ttm) 4.13
PE Ratio 2.45
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151
Open 10.09
Previous Close 10.09
Day's Range 10.09 - 10.09
52-Week Range 9.71 - 11.76
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About PBAX

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California. [Read more...]

Industry Blank Check / SPAC
IPO Date Oct 6, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol PBAX
Full Company Profile


Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021

Oakland, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or more bus...

10 months ago - GlobeNewsWire